Back to search

Ireland· IE-PA-EU/1/09/578/001

Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)

A influenza, inaktiviert, spalt/split virus oder oberflächen-antigen product containing purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1), registered in Ireland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BB02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedAdjupanrix suspension and emulsion fo…ATCJ07BB02REGISTER NO.IE-PA-EU/1/09/578/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BB02 (influenza, inaktiviert, spalt/split virus oder oberflächen-antigen), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen · ATC J07BB02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1)
Manufacturer
GlaxoSmithKline Biologicals S.A.
Country
Ireland (IE)
ATC code
J07BB02
ATC class
Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/09/578/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e45a5457-a577-4a1a-a9d7-483786953f5f
GET /v1/drugs/e45a5457-a577-4a1a-a9d7-483786953f5f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion and suspension for emulsion for injection",
  "routes": [
    "Intramuscular use"
  ],
  "source": "hpra",
  "atc_all": [
    "J07BB",
    "J07BB02"
  ],
  "strength": null,
  "pa_number": "EU/1/09/578/001",
  "substances": [
    "Purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1)"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "05/11/2009",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about influenza, inaktiviert, spalt/split virus oder oberflächen-antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.